[Clinical experimentation with a new enzyme-antibiotic-expectorant combination in the treatment of acute and chronic laryngeo-tracheo-bronchitis].
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001963:Bromelains / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D006140:Guaifenesin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012964:Sodium / Q000627:therapeutic use; D013752:Tetracycline / Q000009:adverse effects / Q000627:therapeutic use*; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D010710:Phosphates; D006140:Guaifenesin; D001963:Bromelains; D012964:Sodium; D013806:Theophylline; D013752:Tetracycline
Experimentação clínica com uma nova associação enzimática-antióbitica-expectorante no tratamento das laringo-traqueo-bronquites agudas e crônicas.